Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The evidence supporting cognitive benefit is observational and mechanistic: GLP-1 receptors exist in dopamine-rich brain regions, preclinical studies show GLP-1 agonists normalize ADHD-like behaviours in rodent models, and cohort studies show modest ADHD symptom reductions in adults treated for obesity
Glucagon-like peptide 1 (GLP-1) is a hormone that triggers the release of insulin, inhibits the secretion of glucagon to prevent blood sugar levels rising, slows the emptying of the stomach and increases satiety
Step therapy means the plan requires trying less expensive alternatives first, and the article names metformin and sulfonylureas as examples, before it will approve a GLP-1
This timeframe applies to single-use or multi-dose vials from licensed 503A compounding pharmacies, which compound medications under strict USP standards to match pharmaceutical-grade quality
Egger et al., 2023
.jpg)
